SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amid speculation of a potential acquisition, with Paramount Skydance reportedly preparing a $71 billion bid. The community is discussing the likelihood of a bidding war, potential involvement of other major players like Netflix and Comcast, and the possible impact of regulatory hurdles. Community talking points include speculation around a potential overbid. 

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

ONDS is trending as investors discuss a recent European contract win and the closing of the Sentrycs acquisition, anticipating positive impacts on revenue and market position. The community is weighing the potential for further gains against concerns about potential share dilution related to these deals. Bullish sentiment is fueled by long-term growth prospects in the drone and counter-UAS sectors, despite some volatility.

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Olema Pharmaceuticals is trending following positive data from Roche on a similar breast cancer drug, sparking significant intraday volatility and a surge in price. The community is actively debating whether this jump is justified, discussing potential short squeezes, imminent offerings, and the overall valuation of OLMA in light of the news. Some traders are wary of a potential pullback, while others see further upside based on pipeline potential and analyst upgrades.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies is trending as investors discuss the company's recent technology upgrade for quantum algorithm simulation, highlighting its compatibility with NVIDIA's CUDA-Q. Community members are focused on the potential for accelerated quantum computing and BTQ's positioning in the sector, with some speculating about partnerships and future growth prospects.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance Corp. ($PSKY) is trending amid rumors of a potential $71 billion bid for Warner Bros. Discovery ($WBD), with community chatter focusing on the deal's likelihood and potential impact. Some traders believe investment banks are actively shorting the stock to suppress its price, while others speculate on potential partnerships and competing bids from companies like Netflix and Comcast.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

MCRB is trending amid ongoing speculation of a potential acquisition by Nestl, with community chatter focusing on the timing and likelihood of a deal. Recent workforce reductions and executive departures have fueled rumors, while some traders point to technical indicators suggesting a potential short squeeze. Uncertainty persists around the company's strategic direction and whether it will pursue a partnership instead of a buyout.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Strike Coin

Starknet (STRK) is trending as analysts highlight its breakout from a rounding-bottom pattern and potential Wave 3 run, with some targeting $0.50. Community excitement is fueled by growing BTCFi integration, increased staking volume, and the network's focus on quantum-resistant technology. Discussions also focus on Starknet's strong performance compared to other Layer-2 solutions and its growing ecosystem.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending amid discussions of a potential LTV contract award and recent insider buying, fueling speculation about the company's future prospects in lunar exploration. The community is weighing the significance of upcoming catalysts like the IM3 mission and the potential for a Saudi investment, while also debating the impact of market conditions and short selling on the stock's performance. Bullish sentiment is building with many highlighting the company's long-term potential in the space sector following recent acquisitions.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending following FDA approval of their first drug, REDEMPLO, for a rare genetic disorder, Familial Chylomicronemia Syndrome (FCS). The community is excited about the potential for revenue generation and the validation of their RNAi platform, with some anticipating a valuation reset and potential for significant upside. Discussions also highlight the drug's competitive advantages, pipeline, and possible expansion into broader indications.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending due to positive clinical trial results for its drug Tradipitant in reducing nausea and vomiting induced by the popular weight loss drug Wegovy. The community is buzzing about the potential buyout scenarios and higher valuation, while some express concerns over management's past decisions and spending habits. Bullish sentiment prevails with many expecting the company's market value to increase significantly.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$XTIA The pieces can really come together if you mark up events on the chart. I hardly believe it, but the $6.5m Iliad promissory note from March 2020 has been hanging over this stock for two years. They were in a tough spot in March 2020, fair enough. So they issued the note at a 30% discount to face value (receiving $5m cash for $6.5m note.) 10% interest rate, and a 5% “monitoring fee” was tacked on after 6 months. These are basically payday loan terms, but the funny thing is this note never had to become a death spiral convertible – in fact, it’s not even technically a convertible! INPX is supposed to settle redemptions in cash, then settle the balance in cash on the maturity date. They could prepay for just 15% penalty, yet (as far as I can tell) they’ve never settled these debts with cash in 4+ years that they’ve had notes like this. This will take a while, but I&#39;ll explain how shitty of a CEO Nadir Ali is. (1/7)

Jaromír

Bent Gronild

John Johnson

APE_I_AM

Ángel Perseo

TheFonz

K man

learningntrading

StockTwits Web

XTI Aerospace Inc.

$INPX The pieces can really come together if you mark up events on the chart. I hardly believe it, but the $6.5m Iliad promissory note from March 2020 has been hanging over this stock for two years. They were in a tough spot in March 2020, fair enough. So they issued the note at a 30% discount to face value (receiving $5m cash for $6.5m note.) 10% interest rate, and a 5% “monitoring fee” was tacked on after 6 months. These are basically payday loan terms, but the funny thing is this note never had to become a death spiral convertible – in fact, it’s not even technically a convertible! INPX is supposed to settle redemptions in cash, then settle the balance in cash on the maturity date. They could prepay for just 15% penalty, yet (as far as I can tell) they’ve never settled these debts with cash in 4+ years that they’ve had notes like this. This will take a while, but I'll explain how shitty of a CEO Nadir Ali is. (1/7)

Jay Hamilton

INPX raised $46m with their 2020 ATM at $1.46 weighted average. They raised $87m net in four offerings and warrant exercises Nov 2020-Feb 2021, at a net weighted average of $1.57. $133m raised during extremely generous market conditions, and they couldn’t pony up ~$7.5m cash to purge the note from the books. Instead, once the notes hit the stage where Iliad is allowed to redeem, they cut these individual agreements where a chunk of the notes are settled with shares. They don’t spell it out for us, but I’ve looked at the timing and pricing of these transactions going back to 2019. Iliad gets shares at a conversion rate of either the average of the previous five closes, or the latest close, whatever’s lower. So they can wait until a day the stock spikes 50% or whatever, call up Ali, and get shares at the cheap price the stock was at before the spike. (2/7)

If you’re Iliad, you wouldn’t issue a redemption notice, wait a day or two for shares to settle, and hope the stock went up in the meantime. You’d just short the day it spiked, and use your cheap shares to cover when they come in. Alternatively, you could just short the stock aggressively on a low volume day, and convert at the closing price. Here’s what that looked like on the two days they converted in 2021. (3/7)

Where this gets really messy is how it ties into the registered direct offerings with Hudson Bay, and their warrants. Each of those offering agreements had typical standstill agreements, basically saying the company wouldn’t do any toxic convertible deals for the entire time Hudson held the warrants. But they allowed an exemption, specifically for this Iliad note, as long as the effective conversion rate was above Hudson’s warrant exercise prices. This is actually the only place I’ve seen Iliad’s conversion terms spelled out. This explains Iliad’s conversion in February. To be honest, I can’t actually explain the conversion in July; either I’m missing a loophole, or that was a breach of the agreements. (4/7)

Fast forward to this year. Iliad’s note was to mature March 18. In the past, conversions usually accelerated when maturity dates approached. But INPX is stuck between a rock and a hard place, unless (God forbid) they settle the remaining ~$4.4m balance with cash. Instead, they cut a deal with Hudson Bay to clear out the warrants. Those 49m warrants were WAY out of the money at this point – they had a weighted average of $1.75, and the stock was at ~$0.40. If you think of them in the way that options are priced, or even in terms of an effective hedge against a short position, these warrants were pretty worthless. Nonetheless, Hudson Bay received 18m shares in exchange for them, kind of like a cashless exercise. The one caveat was this leak-out provision – Hudson Bay couldn’t sell more than 10% of the daily trading volume – until March 29. (5/7)

The volume was pretty low from Jan 28-March 28, so Hudson could have only sold about 9m shares. Assuming VWAP pricing, that would have gotten them ~$3m at $0.35 average. I think the volume and chart speak for themselves on the first two days once leak-out expired. Since it’s the end of quarter, we can confirm this later in Hudson’s 13F, but I bet they got rid of a good chunk of their remaining 9m shares. At ~$0.28 average, that’d mean they liquidated that warrant exchange deal for about $5.5m. (6/7)

The purpose of the leak-out agreement was apparently to keep the selling pressure down while the company entered into share conversions with Iliad. After three conversions, they were left with a balance of about $2.85m on the note, and the company paid a $57k fee to extend the maturity date to March 2023. So a recap – in two years, they chipped away $4m of the balance on that note. Pursuant to that, they issued Iliad 6.1m shares. And indirectly, they issued Hudson Bay 17.8m shares. 24m shares to settle $4m in debt – effectively diluting at $0.17/share. Again, during a span when they raised $133m in the $1.00-$2.00 range. Both John Fife (of Iliad) and Hudson Bay have been charged by the SEC in the past. Nadir Ali is the 800 lb gorilla of shitty CEO’s. (7/7)

Steven Jones

@stompingllama so can we say simply that the stock is dead?

StockTwits for iOS

 so can we say simply that the stock is dead?

Onur celiker

@stompingllama financial crimes are rampant, look at $DSS it is another ENRON

DSS Inc

Garry

@stompingllama hi...but according to your opinion inpixon products are good or bad?

 hi...but according to your opinion inpixon products are good or bad?